Gilead Sciences, Inc. (GILD) pulled back in recent intraday trading as the stock attempts to build positive momentum that could help it break above the upper boundary of a short-term bearish corrective price channel that has constrained its recent movements. At the same time, the stock is trying to overcome the negative pressure exerted by its 50-day Simple Moving Average (SMA). In the background, it is also working to ease some of its overbought conditions on momentum indicators, particularly as negative signals have started to emerge.

Accordingly, our outlook remains tilted to the upside for the stock's upcoming intraday trading sessions, provided it maintains stability above the $157.60 support level. Under this scenario, the stock is expected to target resistance at $137.50.

Today's price forecast: Neutral.